Anavex Life Sciences Corp (AVXL)

[apostrophe]

re:"A2-73 seems to cross blood-brain barrier and is non-toxic so is very good candidate for development but does AVXL has any capacity to develop it further?"

Years of laboratory research have already gone into it. 2-73 is a finished product, already developed. Similarly, 3-71 is the improved version, just not as far along in testing. The pipeline if full enough. In a sense, they have infinite capacity. If they decide they need more lab work, they can contract it out or work with university labs. They have the expertise to decide what kind of work and who would be the best to do it. Do you think they made their own pills for the trials? No, they provided the specs and chose a pill manufacturer.